These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26183700)

  • 1. Ketamine inside neurons?
    Lester HA; Lavis LD; Dougherty DA
    Am J Psychiatry; 2015 Nov; 172(11):1064-6. PubMed ID: 26183700
    [No Abstract]   [Full Text] [Related]  

  • 2. Cracking the moody brain: lifting the mood with ketamine.
    Murrough JW; Charney DS
    Nat Med; 2010 Dec; 16(12):1384-5. PubMed ID: 21135850
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.
    Krystal JH
    Arch Gen Psychiatry; 2010 Nov; 67(11):1110-1. PubMed ID: 21041611
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential link between antidepressant-like effects of ketamine and promotion of adult neurogenesis in the ventral hippocampus of mice.
    Yamada J; Jinno S
    Neuropharmacology; 2019 Nov; 158():107710. PubMed ID: 31310776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking NMDA receptor at rest: a possible alleviation of depression.
    Lu W
    Acta Pharmacol Sin; 2011 Sep; 32(9):1087-8. PubMed ID: 21804573
    [No Abstract]   [Full Text] [Related]  

  • 7. NMDA antagonist treatment of depression.
    Williams NR; Schatzberg AF
    Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
    Li N; Lee B; Liu RJ; Banasr M; Dwyer JM; Iwata M; Li XY; Aghajanian G; Duman RS
    Science; 2010 Aug; 329(5994):959-64. PubMed ID: 20724638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons.
    El Iskandrani KS; Oosterhof CA; El Mansari M; Blier P
    J Psychopharmacol; 2015 Jul; 29(7):792-801. PubMed ID: 25759403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine and the potential role for rapid-acting antidepressant medications.
    Krystal JH
    Swiss Med Wkly; 2007 Apr; 137(15-16):215-6. PubMed ID: 17525875
    [No Abstract]   [Full Text] [Related]  

  • 11. Overcoming Depression by Inhibition of Neural Burst Firing.
    Kim D; Cheong E; Shin HS
    Neuron; 2018 Jun; 98(5):878-879. PubMed ID: 29879390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting glutamate signalling in depression: progress and prospects.
    Murrough JW; Abdallah CG; Mathew SJ
    Nat Rev Drug Discov; 2017 Jul; 16(7):472-486. PubMed ID: 28303025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine and phencyclidine: the good, the bad and the unexpected.
    Lodge D; Mercier MS
    Br J Pharmacol; 2015 Sep; 172(17):4254-76. PubMed ID: 26075331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
    Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
    Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine metabolomics in the treatment of major depression.
    van Velzen M; Dahan A
    Anesthesiology; 2014 Jul; 121(1):4-5. PubMed ID: 24936919
    [No Abstract]   [Full Text] [Related]  

  • 17. How does ketamine elicit a rapid antidepressant response?
    Kavalali ET; Monteggia LM
    Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA-receptor independent actions of ketamine: a new chapter in a story that's not so old.
    Wray NH; Rasenick MM
    Neuropsychopharmacology; 2019 Jan; 44(1):220-221. PubMed ID: 30214059
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive
    Witkin JM; Mitchell SN; Wafford KA; Carter G; Gilmour G; Li J; Eastwood BJ; Overshiner C; Li X; Rorick-Kehn L; Rasmussen K; Anderson WH; Nikolayev A; Tolstikov VV; Kuo MS; Catlow JT; Li R; Smith SC; Mitch CH; Ornstein PL; Swanson S; Monn JA
    J Pharmacol Exp Ther; 2017 Apr; 361(1):68-86. PubMed ID: 28138040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methyl-d-aspartate receptor antagonist ketamine impairs action-monitoring activity in the prefrontal cortex.
    Skoblenick K; Everling S
    J Cogn Neurosci; 2014 Mar; 26(3):577-92. PubMed ID: 24188365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.